1 IDO Inhibitors Market Overview 1.1 Product Overview and Scope of IDO Inhibitors 1.2 IDO Inhibitors Segment by Type 1.2.1 Global IDO Inhibitors Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Dual IDO1/TDO inhibitors 1.2.3 Covalent IDO inhibitors 1.3 IDO Inhibitors Segment by Application 1.3.1 IDO Inhibitors Sales Comparison by Application: (2021-2027) 1.3.2 Metastatic Melanoma 1.3.3 Metastatic Pancreatic Cancer 1.3.4 mCRPC 1.3.5 Malignant Glioma 1.3.6 Astrocytoma 1.3.7 Breast Cancer 1.4 Global IDO Inhibitors Market Size Estimates and Forecasts 1.4.1 Global IDO Inhibitors Revenue 2016-2027 1.4.2 Global IDO Inhibitors Sales 2016-2027 1.4.3 IDO Inhibitors Market Size by Region: 2016 Versus 2021 Versus 2027 2 IDO Inhibitors Market Competition by Manufacturers 2.1 Global IDO Inhibitors Sales Market Share by Manufacturers (2016-2021) 2.2 Global IDO Inhibitors Revenue Market Share by Manufacturers (2016-2021) 2.3 Global IDO Inhibitors Average Price by Manufacturers (2016-2021) 2.4 Manufacturers IDO Inhibitors Manufacturing Sites, Area Served, Product Type 2.5 IDO Inhibitors Market Competitive Situation and Trends 2.5.1 IDO Inhibitors Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest IDO Inhibitors Players Market Share by Revenue 2.5.3 Global IDO Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 IDO Inhibitors Retrospective Market Scenario by Region 3.1 Global IDO Inhibitors Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global IDO Inhibitors Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America IDO Inhibitors Market Facts & Figures by Country 3.3.1 North America IDO Inhibitors Sales by Country 3.3.2 North America IDO Inhibitors Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe IDO Inhibitors Market Facts & Figures by Country 3.4.1 Europe IDO Inhibitors Sales by Country 3.4.2 Europe IDO Inhibitors Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific IDO Inhibitors Market Facts & Figures by Region 3.5.1 Asia Pacific IDO Inhibitors Sales by Region 3.5.2 Asia Pacific IDO Inhibitors Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America IDO Inhibitors Market Facts & Figures by Country 3.6.1 Latin America IDO Inhibitors Sales by Country 3.6.2 Latin America IDO Inhibitors Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa IDO Inhibitors Market Facts & Figures by Country 3.7.1 Middle East and Africa IDO Inhibitors Sales by Country 3.7.2 Middle East and Africa IDO Inhibitors Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global IDO Inhibitors Historic Market Analysis by Type 4.1 Global IDO Inhibitors Sales Market Share by Type (2016-2021) 4.2 Global IDO Inhibitors Revenue Market Share by Type (2016-2021) 4.3 Global IDO Inhibitors Price by Type (2016-2021) 5 Global IDO Inhibitors Historic Market Analysis by Application 5.1 Global IDO Inhibitors Sales Market Share by Application (2016-2021) 5.2 Global IDO Inhibitors Revenue Market Share by Application (2016-2021) 5.3 Global IDO Inhibitors Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Pfizer 6.1.1 Pfizer Corporation Information 6.1.2 Pfizer Description and Business Overview 6.1.3 Pfizer IDO Inhibitors Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Pfizer Product Portfolio 6.1.5 Pfizer Recent Developments/Updates 6.2 Bristol-Myers Squibb 6.2.1 Bristol-Myers Squibb Corporation Information 6.2.2 Bristol-Myers Squibb Description and Business Overview 6.2.3 Bristol-Myers Squibb IDO Inhibitors Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Bristol-Myers Squibb Product Portfolio 6.2.5 Bristol-Myers Squibb Recent Developments/Updates 6.3 Kyowa Hakko Kirin 6.3.1 Kyowa Hakko Kirin Corporation Information 6.3.2 Kyowa Hakko Kirin Description and Business Overview 6.3.3 Kyowa Hakko Kirin IDO Inhibitors Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Kyowa Hakko Kirin Product Portfolio 6.3.5 Kyowa Hakko Kirin Recent Developments/Updates 7 IDO Inhibitors Manufacturing Cost Analysis 7.1 IDO Inhibitors Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of IDO Inhibitors 7.4 IDO Inhibitors Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 IDO Inhibitors Distributors List 8.3 IDO Inhibitors Customers 9 IDO Inhibitors Market Dynamics 9.1 IDO Inhibitors Industry Trends 9.2 IDO Inhibitors Growth Drivers 9.3 IDO Inhibitors Market Challenges 9.4 IDO Inhibitors Market Restraints 10 Global Market Forecast 10.1 IDO Inhibitors Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of IDO Inhibitors by Type (2022-2027) 10.1.2 Global Forecasted Revenue of IDO Inhibitors by Type (2022-2027) 10.2 IDO Inhibitors Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of IDO Inhibitors by Application (2022-2027) 10.2.2 Global Forecasted Revenue of IDO Inhibitors by Application (2022-2027) 10.3 IDO Inhibitors Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of IDO Inhibitors by Region (2022-2027) 10.3.2 Global Forecasted Revenue of IDO Inhibitors by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global IDO Inhibitors Sales (MT) Growth Rate Comparison by Type (2021-2027) Table 2. Global IDO Inhibitors Sales (MT) Comparison by Application (2021-2027) Table 3. Global IDO Inhibitors Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers IDO Inhibitors Covered in This Study Table 5. Global IDO Inhibitors Sales (MT) of Key Manufacturers (2016-2021) Table 6. Global IDO Inhibitors Sales Share by Manufacturers (2016-2021) Table 7. Global IDO Inhibitors Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global IDO Inhibitors Revenue Share by Manufacturers (2016-2021) Table 9. Global Market IDO Inhibitors Average Price (USD/MT) of Key Manufacturers (2016-2021) Table 10. Manufacturers IDO Inhibitors Manufacturing Sites and Area Served Table 11. Manufacturers IDO Inhibitors Product Type Table 12. Global IDO Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global IDO Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in IDO Inhibitors as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global IDO Inhibitors Sales by Region (2016-2021) & (MT) Table 16. Global IDO Inhibitors Sales Market Share by Region (2016-2021) Table 17. Global IDO Inhibitors Revenue by Region (2016-2021) & (US$ Million) Table 18. North America IDO Inhibitors Sales by Country (2016-2021) & (MT) Table 19. North America IDO Inhibitors Sales Market Share by Country (2016-2021) Table 20. North America IDO Inhibitors Revenue by Country (2016-2021) & (US$ Million) Table 21. North America IDO Inhibitors Revenue Market Share by Country (2016-2021) Table 22. Europe IDO Inhibitors Sales by Country (2016-2021) & (MT) Table 23. Europe IDO Inhibitors Sales Market Share by Country (2016-2021) Table 24. Europe IDO Inhibitors Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe IDO Inhibitors Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific IDO Inhibitors Sales by Region (2016-2021) & (MT) Table 27. Asia Pacific IDO Inhibitors Sales Market Share by Region (2016-2021) Table 28. Asia Pacific IDO Inhibitors Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific IDO Inhibitors Revenue Market Share by Region (2016-2021) Table 30. Latin America IDO Inhibitors Sales by Country (2016-2021) & (MT) Table 31. Latin America IDO Inhibitors Sales Market Share by Country (2016-2021) Table 32. Latin America IDO Inhibitors Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America IDO Inhibitors Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa IDO Inhibitors Sales by Country (2016-2021) & (MT) Table 35. Middle East and Africa IDO Inhibitors Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa IDO Inhibitors Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa IDO Inhibitors Revenue Market Share by Country (2016-2021) Table 38. Global IDO Inhibitors Sales (MT) by Type (2016-2021) Table 39. Global IDO Inhibitors Sales Market Share by Type (2016-2021) Table 40. Global IDO Inhibitors Revenue (Million US$) by Type (2016-2021) Table 41. Global IDO Inhibitors Revenue Share by Type (2016-2021) Table 42. Global IDO Inhibitors Price (USD/MT) by Type (2016-2021) Table 43. Global IDO Inhibitors Sales (MT) by Application (2016-2021) Table 44. Global IDO Inhibitors Sales Market Share by Application (2016-2021) Table 45. Global IDO Inhibitors Revenue (Million US$) by Application (2016-2021) Table 46. Global IDO Inhibitors Revenue Share by Application (2016-2021) Table 47. Global IDO Inhibitors Price (USD/MT) by Application (2016-2021) Table 48. Pfizer Corporation Information Table 49. Pfizer Description and Business Overview Table 50. Pfizer IDO Inhibitors Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 51. Pfizer IDO Inhibitors Product Table 52. Pfizer Recent Developments/Updates Table 53. Bristol-Myers Squibb Corporation Information Table 54. Bristol-Myers Squibb Description and Business Overview Table 55. Bristol-Myers Squibb IDO Inhibitors Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 56. Bristol-Myers Squibb IDO Inhibitors Product Table 57. Bristol-Myers Squibb Recent Developments/Updates Table 58. Kyowa Hakko Kirin Corporation Information Table 59. Kyowa Hakko Kirin Description and Business Overview Table 60. Kyowa Hakko Kirin IDO Inhibitors Sales (MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 61. Kyowa Hakko Kirin IDO Inhibitors Product Table 62. Kyowa Hakko Kirin Recent Developments/Updates Table 63. Production Base and Market Concentration Rate of Raw Material Table 64. Key Suppliers of Raw Materials Table 65. IDO Inhibitors Distributors List Table 66. IDO Inhibitors Customers List Table 67. IDO Inhibitors Market Trends Table 68. IDO Inhibitors Growth Drivers Table 69. IDO Inhibitors Market Restraints Table 70. Global IDO Inhibitors Sales Forecast by Type (2022-2027) & (MT) Table 71. Global IDO Inhibitors Sales Market Share Forecast by Type (2022-2027) Table 72. Global IDO Inhibitors Revenue Forecast by Type (2022-2027) & (US$ Million) Table 73. Global IDO Inhibitors Revenue Market Share Forecast by Type (2022-2027) Table 74. Global IDO Inhibitors Sales Forecast by Application (2022-2027) & (MT) Table 75. Global IDO Inhibitors Sales Market Share Forecast by Application (2022-2027) Table 76. Global IDO Inhibitors Revenue Forecast by Application (2022-2027) & (US$ Million) Table 77. Global IDO Inhibitors Revenue Market Share Forecast by Application (2022-2027) Table 78. Global IDO Inhibitors Sales Forecast by Region (2022-2027) & (MT) Table 79. Global IDO Inhibitors Sales Market Share Forecast by Region (2022-2027) Table 80. Global IDO Inhibitors Revenue Forecast by Region (2022-2027) & (US$ Million) Table 81. Global IDO Inhibitors Revenue Market Share Forecast by Region (2022-2027) Table 82. Research Programs/Design for This Report Table 83. Key Data Information from Secondary Sources Table 84. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of IDO Inhibitors Figure 2. Global IDO Inhibitors Market Share by Type in 2020 & 2027 Figure 3. Dual IDO1/TDO inhibitors Product Picture Figure 4. Covalent IDO inhibitors Product Picture Figure 5. Global IDO Inhibitors Market Share by Application in 2020 & 2027 Figure 6. Metastatic Melanoma Figure 7. Metastatic Pancreatic Cancer Figure 8. mCRPC Figure 9. Malignant Glioma Figure 10. Astrocytoma Figure 11. Breast Cancer Figure 12. Global IDO Inhibitors Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global IDO Inhibitors Market Size 2016-2027 (US$ Million) Figure 14. Global IDO Inhibitors Sales 2016-2027 (MT) Figure 15. Global IDO Inhibitors Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 16. IDO Inhibitors Sales Share by Manufacturers in 2020 Figure 17. Global IDO Inhibitors Revenue Share by Manufacturers in 2020 Figure 18. The Global 5 and 10 Largest IDO Inhibitors Players: Market Share by Revenue in 2020 Figure 19. IDO Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 20. Global IDO Inhibitors Sales Market Share by Region (2016-2021) Figure 21. Global IDO Inhibitors Sales Market Share by Region in 2020 Figure 22. Global IDO Inhibitors Revenue Market Share by Region (2016-2021) Figure 23. Global IDO Inhibitors Revenue Market Share by Region in 2020 Figure 24. U.S. IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. Canada IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Germany IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. France IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. U.K. IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Italy IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Russia IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. China IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Japan IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. South Korea IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. India IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Australia IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Taiwan IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Indonesia IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Thailand IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Malaysia IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Philippines IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Vietnam IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Mexico IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Brazil IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Argentina IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Turkey IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Saudi Arabia IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. U.A.E IDO Inhibitors Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Sales Market Share of IDO Inhibitors by Type (2016-2021) Figure 49. Sales Market Share of IDO Inhibitors by Application (2016-2021) Figure 50. Sales Market Share of IDO Inhibitors by Application in 2020 Figure 51. Revenue Share of IDO Inhibitors by Application (2016-2021) Figure 52. Revenue Share of IDO Inhibitors by Application in 2020 Figure 53. Manufacturing Cost Structure of IDO Inhibitors Figure 54. Manufacturing Process Analysis of IDO Inhibitors Figure 55. IDO Inhibitors Industrial Chain Analysis Figure 56. Channels of Distribution Figure 57. Distributors Profiles Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

Pfizer Bristol-Myers Squibb Kyowa Hakko Kirin